Mises Daily
Author:
Ilana Mercer
Online Publish Date:
Bayer AG, the German pharmaceutical giant and manufacturer of the anthrax-fighting drug Cipro, is experiencing a windfall . The sudden demand for Cipro could not have come at a better time for a company that had been in a slump and was hemorrhaging due to a considerable operating-profit shortfall. The financial press’s accounts of how Bayer was